Archaeosomes: an excellent carrier for drug and cell delivery

Drug Delivery

Volumn 23, Issue 7, 2016, Pages 2497-2512

  Kaur, Gurmeet ^a   Garg, Tarun ^a   Rath, Goutam ^a   Goyal, Amit K ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Archaeobacteria; archaeosomes; cell delivery; drug delivery; gene delivery

Indexed keywords

ANTIOXIDANT; ARCHAEOSOME; BILE SALT; CANCER VACCINE; IMMUNOLOGICAL ADJUVANT; LIPID; LIPOSOME; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ARCHAEOL LIPID; CALDARCHAEOL; DRUG CARRIER; GLYCEROL ETHER; PEPTIDE;

ANTIGEN DELIVERY SYSTEM; ARCHAEON; BLOOD ANALYSIS; CELL DELIVERY SYSTEM; CELL ENCAPSULATION; CELL GROWTH; CHAGAS DISEASE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; DETERGENT DIALYSIS METHOD; DILUTION; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; ENZYME STABILITY; EPITHELIUM CELL; EXTRACTION; FREEZE THAWING; FRENCH PRESSURE CELL EXTRUSION; GENE DELIVERY SYSTEM; HUMAN; IN VITRO STUDY; INSTRUMENT STERILIZATION; INVESTIGATIVE PROCEDURES; LIPID EXTRACTION; LIPID HYDRATION METHOD; MECHANICAL DISPERSION METHOD; MEMBRANE EXTRUSION; NONHUMAN; ORAL DRUG DELIVERY SYSTEM; PH; PRIORITY JOURNAL; REVERSE PHASE EVAPORATION; REVIEW; SOLVENT DISPERSION METHOD; THERMOSTABILITY; TOPICAL DRUG DELIVERY SYSTEM; ULTRASOUND; CHEMISTRY; DRUG STABILITY; GENE TRANSFER; METABOLISM; PROCEDURES;

ADJUVANTS, IMMUNOLOGIC; ARCHAEA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GENE TRANSFER TECHNIQUES; GLYCERYL ETHERS; HUMANS; LIPOSOMES; PEPTIDES;

EID: 84991677363     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1019653     Document Type: Review

References (97)

1. S.E.Alavi, H.Mansouri, M.K.M.Esfahani,. (2014). Archaeosome:as new drug carrier for delivery of paclitaxel to breast cancer. Indian J Clin Biochem 29:150–3
2. C.Alving, V.Koulchin, G.M.Glenn, M.Rao. (1995). Liposomes as carriers of peptide antigens:induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol Rev 145:5–31
3. A.Bangham. (1993). Liposomes:the Babraham connection. Chem Phys Lipids, 64:275–85
4. T.Benvegnu, L.Lemiègre, S.Cammas-Marion. (2009). New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery. Recent pat Drug Deliv Formul 3:206–20
5. T.Benvegnu, L.Lemiègre, S.Dalençon, J.Jeftic. (2013). Applications of extremophilic archaeal lipids in the field of nanocarriers for oral/topical drug delivery. Curr Biotechnol 2:294–303
6. D.A.Brown, B.Venegas, P.H.Cooke,. (2009). Bipolar tetraether archaeosomes exhibit unusual stability against autoclaving as studied by dynamic light scattering and electron microscopy. Chem Phys Lipids 159:95–103
7. D.C.Carrer, L.H.Higa, M.V.D.Tesoriero,. (2014). Structural features of ultradeformable archaeosomes for topical delivery of ovalbumin. Colloids Surf B Biointerfaces 121:281–9
8. S.Chaudhary, T.Garg, R.S.Murthy,. (2014). Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target 10:871–82
9. C.G.Choquet, G.B.Patel, T.Beveridge, G.Sprott. (1992). Formation of unilamellar liposomes from total polar lipid extracts of methanogens. Appl Environ Microbiol 58:2894–900
10. C.G.Choquet, G.B.Patel, G.D.Sprott. (1996). Heat sterilization of archaeal liposomes. Can J Microbiol 42:183–6
11. C.G.Choquet, G.B.Patel, G.D.Sprott, T.J.Beveridge. (1993). Stable liposomes formed from archaeal ether lipids. Advances in bacterial paracrystalline surface layers. Springer US, 252:257–68
12. S.Conti, L.Polonelli, R.Frazzi,. (2000). Controlled delivery of biotechnological products. Curr Pharm Biotechnol 1:313–23
13. M.Edgerton, M.J.Levine. (1993). Biocompatibility:its future in prosthodontic research. J Prosth Dent 69:406–15
14. G.T.Gagandeep, Garg T, B.Malik,. (2014). Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci 53:10–16
15. T.Garg. (2014). Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. Early Online, 1–8. DOI:10.3109/21691401.2014.916715
16. T.Garg, A.K.Goyal. (2012). Iontophoresis:drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett 2:270–80
17. T.Garg, A.K.Goyal. (2014a). Biomaterial-based scaffolds – current status and future directions. Exp Opin Drug Deliv 11:767–89
18. T.Garg, A.K.Goyal. (2014b). Liposomes:targeted and controlled delivery system. Drug Deliv Lett 4:62–71
19. T.Garg, A.K.Goyal. (2014c). Medicated chewing gum:patient compliance oral drug delivery system. Drug Deliv Lett 4:72–8
20. T.Garg, A.K.Goyal, S.Arora, R.Murthy. (2012a). Development, optimization & evaluation of porous chitosan Scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett 2:251–61
21. T.Garg, A.Kumar, G.Rath, A.K.Goyal. (2014a). Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Crit Rev Ther Drug Carrier Syst 31:531–57
22. T.Garg, G.Rath, A.K.Goyal. (2014b). Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst 31:331–64
23. T.Garg, G.Rath, A.K.Goyal. (2014c). Biomaterials-based nanofiber scaffold:targeted and controlled carrier for cell and drug delivery. J Drug Target. Early Online, 1–20. DOI:10.3109/1061186X.2014.992899
24. T.Garg, G.Rath, A.K.Goyal. (2014d). Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv. Early Online, 1–19. DOI:10.3109/10717544.2013.879355
25. T.Garg, O.Singh, S.Arora, R.Murthy. (2011a). Dendrimer—a novel scaffold for drug delivery. Int J Pharm Sci Rev Res 7:211–20
26. T.Garg, O.Singh, S.Arora, R.Murthy. (2011b). Patented microencapsulation techniques and its application. J Pharmacy Res 4:2097–102
27. T.Garg, O.Singh, S.Arora, R.Murthy. (2012b). Scaffold:a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29:1–63
28. T.Garg, S.Singh, A.K.Goyal. (2013). Stimuli-sensitive hydrogels:an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 30:369–409
29. R.O.Gonzalez, L.H.Higa, R.A.Cutrullis,. (2009). Archaeosomes made of Halorubrum tebenquichense total polar lipids:a new source of adjuvancy. BMC Biotechnol 9:71
30. A.González-Paredes, B.Clarés-naveros, M.Ruiz-martínez,. (2011). Delivery systems for natural antioxidant compounds:archaeosomes and archaeosomal hydrogels characterization and release study. Int J Pharm 421:321–31
31. A.González-Paredes, M.Manconi, C.Caddeo,. (2010). Archaeosomes as carriers for topical delivery of betamethasone dipropionate:in vitro skin permeation study. J Liposome Res 20:269–76
32. A.K.Goyal, G.Rath, T.Garg. (2013a). Nanotechnological approaches for genetic immunization. DNA and RNA nanobiotechnologies in medicine:diagnosis and treatment of diseases. Springer Berlin Heidelberg 67–120
33. G.Goyal, T.Garg, B.Malik,. (2013b). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. Early Online, 1–16. doi:10.3109/10717544.2013.855277
34. G.Goyal, T.Garg, G.Rath, A.K.Goyal. (2014a). Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst 31:89–119
35. G.Goyal, T.Garg, G.Rath, A.K.Goyal. (2014b). Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst 31:365–405
36. G.Gregoriadis. (1995). Engineering liposomes for drug delivery:progress and problems. Trends Biotechnol 13:527–37
37. L.H.Higa, R.S.Corral, M.J.Morilla,. (2013). Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease. Human Vac Immunother 9:409–12
38. L.H.Higa, P.Schilrreff, A.P.Perez,. (2012). Ultradeformable archaeosomes as new topical adjuvants. Nanomed Nanotechnol Biol Med 8:1319–28
39. T.Hussain, T.Garg, A.K.Goyal, G.Rath. (2014). Biomedical applications of nanofiber scaffolds in tissue engineering. J Biomater Tissue Eng 4:600–23
40. S.Jain, A.Caforio, A.J.Driessen. (2014). Biosynthesis of archaeal membrane ether lipids. Microbial Physiol Metab 5:641–59
41. H.S.Johal, T.Garg, G.Rath, A.K.Goyal. (2014). Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. Early Online, 1–14. DOI:10.3109/10717544.2014.928760
42. D.Joshi, T.Garg, A.K.Goyal, G.Rath. (2014a). Advanced drug delivery approaches against periodontitis. Drug Deliv. Early Online, 1–15. DOI:10.3109/10717544.2014.935531
43. D.Joshi, T.Garg, A.K.Goyal, G.Rath. (2014b). Development and characterization of novel medicated nanofibers against periodontitis. Curr Drug Deliv. Early Online, 1–12. DOI:10.2174/1567201811666141117144332
44. V.Kalia, T.Garg, G.Rath, A.K.Goyal. (2014). Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride. Artif Cells Nanomed Biotechnol. Early Online, 1–5. DOI:10.3109/21691401.2014.984303
45. K.Kataria, A.Sharma, T.Garg,. (2014). Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett 4:79–86
46. M.Kaur, T.Garg, R.K.Narang. (2014a). A review of emerging trends in the treatment of tuberculosis. Artif Cells Nanomed Biotechnol. Early Online, 1–7. DOI:10.3109/21691401.2014.962745
47. M.Kaur, T.Garg, G.Rath, A.K.Goyal. (2014b). Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31:49–88
48. M.Kaur, B.Malik, T.Garg,. (2014c). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv. Early Online, 1–7. DOI:10.3109/10717544.2014.894594
49. N.Kaur, T.Garg, A.K.Goyal, G.Rath. (2014d). Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv. Early Online, 1–10. DOI:10.3109/10717544.2014.963900
50. P.Kaur, T.Garg, G.Rath,. (2014e). Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box–Behnken design. Drug Deliv. Early Online, 1–14. DOI:10.3109/10717544.2014.993486
51. P.Kaur, T.Garg, G.Rath,. (2014f). Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv. Early Online, 1–12. DOI:10.3109/10717544.2014.935530
52. P.Kaur, T.Garg, B.Vaidya,. (2014g). Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug:behavioral and biochemical assessment. J Drug Target 1–12. DOI:10.3109/1061186X.2014.994097
53. R.Kaur, T.D.G.U.GargT, Das Gupta U,. (2014h). Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. Early Online, 1–6. DOI:10.3109/21691401.2014.930747
54. R.Kaur, T.Garg, B.Malik,. (2014i). Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv. Early Online, 1–6. DOI:10.3109/10717544.2014.920428
55. R.Kaur, T.Garg, G.Rath, A.K.Goyal. (2014j). Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit Rev Ther Drug Carrier Syst 31:495–530
56. V.Kaur, T.Garg, G.Rath, A.K.Goyal. (2014k). Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target 1–12. DOI:10.3109/1061186X.2014.947295
57. H.Kikuchi, A.Carlsson, K.Yachi, S.Hirota. (1991). Possibility of heat sterilization of liposomes. Chem Pharm Bull 39:1018–22
58. V.Kirilenko, G.Gregoriadis. (1993). Fat soluble vitamins in liposomes:studies on incorporation efficiency and bile salt induced vesicle disintegration. J Drug Target 1:361–8
59. L.Krishnan, G.Dennis Sprott. (2003). Archaeosomes as self-adjuvanting delivery systems for cancer vaccines. J Drug Target 11:515–24
60. L.Krishnan, C.J.Dicaire, G.B.Patel, G.D.Sprott. (2000). Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses:comparison to conventional liposomes and alum. Infect Immun 68:54–63
61. L.Krishnan, S.Sad, G.B.Patel, G.D.Sprott. (2003). Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge. Cancer Res 63:2526–34
62. L.Krishnan, G.D.Sprott. (2007). Archaeosome vaccine adjuvants for cross-priming CD8 + T cell immunity. Vaccine adjuvants and delivery systems. Wiley Online Library 263–94
63. Z.Li, J.Chen, W.Sun, Y.Xu. (2010). Investigation of archaeosomes as carriers for oral delivery of peptides. Biochem Biophys Res Commun 394:412–17
64. Z.Li, L.Zhang, W.Sun,. (2011). Archaeosomes with encapsulated antigens for oral vaccine delivery. Vaccine 29:5260–6
65. R.Malik, T.Garg, A.K.Goyal, G.Rath. (2014). Polymeric nanofibers:targeted gastro-retentive drug delivery systems. J Drug Target 1–16. DOI:10.3109/1061186X.2014.965715
66. H.Marwah, T.Garg, A.K.Goyal, G.Rath. (2014). Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. Early Online, 1–15. DOI:10.3109/10717544.2014.935532
67. V.Modgill, T.Garg, A.K.Goyal, G.Rath. (2014a). Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol. Early Online, 1–6. DOI:10.3109/21691401.2014.924007
68. V.Modgill, T.Garg, A.K.Goyal, G.Rath. (2014b). Transmucosal delivery of linagliptin for the treatment of type-2 diabetes mellitus by ultra-thin nanofibers. Curr Drug Deliv. Early Online, 1–10. doi:10.2174/1567201811666141117144332
69. A.Morie, T.Garg, A.K.Goyal, G.Rath. (2014). Nanofibers as novel drug carrier – an overview. Artif Cells Nanomed Biotechnol 1–9
70. T.Napotnik, J.Valant, D.Gmajner,. (2013). Cytotoxicity and uptake of archaeosomes prepared from Aeropyrum pernix lipids. Human Exp Toxicol 32:950–9
71. S.Pabreja, T.Garg, G.Rath, A.K.Goyal. (2014). Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes. Artif Cells Nanomed Biotechnol. Early Online, 1–8. DOI:10.3109/21691401.2014.966195
72. G.B.Patel, W.Chen. (2005). Archaeosome immunostimulatory vaccine delivery system. Curr Drug Deliv 2:407–21
73. G.B.Patel, W.Chen. (2006). Archaeosomes as drug and vaccine nanodelivery systems. Nanocarrier technologies. Springer Netherlands, 17–40
74. G.B.Patel, A.Omri, L.Deschatelets, G.Dennis Sprott. (2002). Safety of archaeosome adjuvants evaluated in a mouse model 1. J Liposome Res 12:353–72
75. G.B.Patel, G.D.Sprott. (1999). Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. Crit Rev Biotechnol 19:317–57
76. Y.Perrie, D.Kirby, V.W.Bramwell, A.R.Mohammed. (2007). Recent developments in particulate-based vaccines. Recent Pat Drug Deliv Formul 1:117–29
77. A.Relini, D.Cassinadri, Q.Fan,. (1996). Effect of physical constraints on the mechanisms of membrane fusion:bolaform lipid vesicles as model systems. Biophys J 71:1789–95
78. X.Ren, K.Liu, Q.Zhang,. (2014). Design, fabrication, and characterization of archaeal tetraether free-standing planar membranes in a PDMS- and PCB-based fluidic platform. ACS Appl Mater Interfaces 6:12618–28
79. G.Réthoré, T.Montier, T.Le Gall,. (2007). Archaeosomes based on synthetic tetraether-like lipids as novel versatile gene delivery systems. Chem Commun 20:2054–6
80. R.Rohilla, T.Garg, J.Bariwal,. (2014a). Development, optimization and characterization of glycyrrhetinic acid–chitosan nanoparticles of atorvastatin for liver targeting. Drug Deliv. Early Online, 1–8. DOI:10.3109/10717544.2014.977460
81. R.Rohilla, T.Garg, A.K.Goyal, G.Rath. (2014b). Herbal and polymeric approaches for liver-targeting drug delivery:novel strategies and their significance. Drug Deliv. Early Online, 1–17. DOI:10.3109/10717544.2014.945018
82. A.Sharma, T.Garg, A.Aman,. (2014a). Nanogel – an advanced drug delivery tool:current and future. Artif Cells Nanomed Biotechnol. Early Online, 1–13. DOI:10.3109/21691401.2014.930745
83. R.Sharma, T.Garg, A.K.Goyal, G.Rath. (2014b). Development, optimization and evaluation of polymeric electrospun nanofiber:a tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. Early Online, 1–8. DOI:10.3109/21691401.2014.966194
84. R.Sharma, H.Singh, M.Joshi,. (2014c). Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst 31:187–217
85. B.Singh, T.Garg, A.K.Goyal, G.Rath. (2014a). Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol 1–10
86. H.Singh, R.Sharma, M.Joshi,. (2014b). Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol. Early Online, 1–10. doi:10.3109/21691401.2014.885442
87. K.Singh, N.Arora, T.Garg. (2012a). RFID:a trustable security tool in pharmaceutical industry. Am J Pharm Tech Res 2:113–27
88. K.Singh, N.Arora, T.Garg. (2012b). Superbug:antimicrobial resistance due to NDM-1. Int J Inst Pharmacy Life Sci 2:58–66
89. O.Singh, T.Garg, G.Rath, A.K.Goyal. (2014c). Microbicides for the treatment of sexually transmitted HIV infections. J Pharm 1–18. DOI:org/10.1155/2014/352425
90. G.D.Sprott, D.L.Tolson, G.B.Patel. (1997). Archaeosomes as novel antigen delivery systems 1. FEMS Microbiol Lett 154:17–22
91. F.SzokaJr, D.Papahadjopoulos. (1980). Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng 9:467–508
92. J.L.Vossenberg, T.Ubbink-Kok, M.G.Elferink,. (1995). Ion permeability of the cytoplasmic membrane limits the maximum growth temperature of bacteria and archaea. Mol Microbiol 18:925–932
93. D.C.Whitcomb, M.E.Lowe. (2007). Human pancreatic digestive enzymes. Digest Dis Sci 52:1–17
94. M.C.Woodle, D.D.Lasic. (1992). Sterically stabilized liposomes. Biochim Biophys Acta Rev Biomembr 1113:171–99
95. K.Yamauchi, K.Doi, M.Kinoshita,. (1992). Archaebacterial lipid models:highly salt-tolerant membranes from 1,2-diphytanylglycero-3-phosphocholine. Biochim Biophys Acta Biomembr 1110:171–7
96. A.B.Zavec, A.Ota, T.Zupancic,. (2014). Archaeosomes can efficiently deliver different types of cargo into epithelial cells grown in vitro. J Biotechnol 192 A:130–5
97. N.J.Zuidam, S.S.Lee, D.J.Crommelin. (1993). Sterilization of liposomes by heat treatment. Pharm Res, 10:1591–6